Elironrasib (RMC-6291) CAS No.: 2641998-63-0 is an orally active and covalent inhibitor of KRAS G12C(ON). Elironrasib forms a tri-complex within tumor cells between KRAS G12C(ON) and cyclophilin A (CypA). Thus, Elironrasib prevents KRAS G12C(ON) from signaling via steric blockade of RAS effector binding. Elironrasib inhibits ERK signaling and induced apoptosis in KRASG12C-mutant H358 cells. Elironrasib also inhibits the proliferation of KRAS G12C mutant cells with a median IC50 of 0.11 nM .
Related Products:
Daraxonrasib (RMC-6236) CAS No.: 2765081-21-6 https://www.chemshuttle.com/catalogsearch/result/?q=2765081-21-6&cat=
Zoldonrasib (RMC-9805; KRAS G12D inhibitor 18) CAS No.: 2922732-54-3 https://www.chemshuttle.com/catalogsearch/result/?q=2922732-54-3&cat=
RMC-7977 CAS No.: 2765082-12-8 https://www.chemshuttle.com/catalogsearch/result/?q=2765082-12-8&cat=
RMC-4998 CAS No.: 2642037-07-6 https://www.chemshuttle.com/catalogsearch/result/?q=2642037-07-6&cat=
RMC-5127 CAS No.: 3056146-38-1 https://www.chemshuttle.com/catalogsearch/result/?q=3056146-38-1&cat=
RM-018 CAS No.: 2641993-55-5 https://www.chemshuttle.com/catalogsearch/result/?q=2641993-55-5&cat=
RAS/RAS-RAF-IN-1 CAS No.: 2447039-81-6 https://www.chemshuttle.com/catalogsearch/result/?q=2447039-81-6&cat=